Phoslo and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phoslo (calcium acetate) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include lethargy among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Phoslo and Cipro. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.



On Jul, 11, 2026

57 people who take Phoslo and Cipro together, and have interactions are studied.

Phoslo and Cipro drug interactions.

What are the common drug interactions of Phoslo and Cipro, by gender? *:

female:

  1. Lethargy (tiredness)
  2. Surgery
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Hypertension (high blood pressure)
  6. Hypophagia (reduced food intake)
  7. Impaired healing
  8. Unresponsive to stimuli
  9. Abdominal distension
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

  1. Vomiting
  2. Nausea (feeling of having an urge to vomit)
  3. Blood pressure immeasurable
  4. Decreased appetite
  5. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  6. Cough
  7. Oedema (fluid collection in tissue)
  8. Pain
  9. Pericardial effusion (fluid around the heart)
  10. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

What are the common drug interactions of Phoslo and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal abscess (collection of pus in abdomen)
  2. Adhesion
  3. Dehydration (dryness resulting from the removal of water)
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Intestinal stenosis (partial obstruction that causes the centre opening of the intestine to become narrower)
  6. Erythema (redness of the skin)
  7. Oxygen saturation decreased
  8. Post procedural complication
  9. Pruritus (severe itching of the skin)
  10. Wheezing (a high-pitched whistling sound made while you breath)

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Pyrexia (fever)
  3. Vomiting
  4. Asthenia (weakness)
  5. Blood pressure immeasurable
  6. Decreased appetite
  7. Dizziness
  8. Hypotension (abnormally low blood pressure)
  9. Nausea (feeling of having an urge to vomit)
  10. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

50-59:

  1. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  2. Abdominal pain
  3. Anaemia (lack of blood)
  4. Anticoagulation drug level above therapeutic
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Blood pressure immeasurable
  7. Cardiac arrest
  8. Death
  9. Decreased activity
  10. Diarrhoea

60+:

  1. Diarrhoea
  2. Asthenia (weakness)
  3. Vomiting
  4. Cardiac failure congestive
  5. Cardioactive drug level increased
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  8. Hyperlipidaemia (presence of excess lipids in the blood)
  9. Lethargy (tiredness)
  10. Pain

What are the existing conditions these people have? *

  1. Pain: 8 people, 14.04%
  2. Chronic Renal Failure (kidney failure): 6 people, 10.53%
  3. Multiple Myeloma (cancer of the plasma cells): 5 people, 8.77%
  4. Anaemia (lack of blood): 4 people, 7.02%
  5. Nausea (feeling of having an urge to vomit): 3 people, 5.26%
  6. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 5.26%
  7. Fever: 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Phoslo and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phoslo and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcium acetate and ciprofloxacin hydrochloride (the active ingredients of Phoslo and Cipro, respectively), and Phoslo and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: